Attributes | Values |
---|
rdf:type
| |
Description
| - As positron emission tomography (PET) seems to be a powerful prognostic marker in the treatment of Hodgkin´s lymphoma (HL), we analysed the prognostic value of PET after four cycles of combination therapy with bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine and prednisone (BEACOPP) in patients with advanced-stage HL. Our results indicate a very good negative predictive value of PET-4 in advanced -stage HL patients treated with BEACOPP.
- As positron emission tomography (PET) seems to be a powerful prognostic marker in the treatment of Hodgkin´s lymphoma (HL), we analysed the prognostic value of PET after four cycles of combination therapy with bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine and prednisone (BEACOPP) in patients with advanced-stage HL. Our results indicate a very good negative predictive value of PET-4 in advanced -stage HL patients treated with BEACOPP. (en)
- As positron emission tomography (PET) seems to be a powerful prognostic marker in the treatment of Hodgkin´s lymphoma (HL), we analysed the prognostic value of PET after four cycles of combination therapy with bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine and prednisone (BEACOPP) in patients with advanced-stage HL. Our results indicate a very good negative predictive value of PET-4 in advanced -stage HL patients treated with BEACOPP. (cs)
|
Title
| - FDG-PET for assessment of early treatment response after four cycles of chemotherapy in patients with advanced-stage Hodgkin´s lymphoma has a high negative predictive value
- FDG-PET for assessment of early treatment response after four cycles of chemotherapy in patients with advanced-stage Hodgkin´s lymphoma has a high negative predictive value (cs)
- FDG-PET for assessment of early treatment response after four cycles of chemotherapy in patients with advanced-stage Hodgkin´s lymphoma has a high negative predictive value. (en)
|
skos:prefLabel
| - FDG-PET for assessment of early treatment response after four cycles of chemotherapy in patients with advanced-stage Hodgkin´s lymphoma has a high negative predictive value
- FDG-PET for assessment of early treatment response after four cycles of chemotherapy in patients with advanced-stage Hodgkin´s lymphoma has a high negative predictive value (cs)
- FDG-PET for assessment of early treatment response after four cycles of chemotherapy in patients with advanced-stage Hodgkin´s lymphoma has a high negative predictive value. (en)
|
skos:notation
| - RIV/00064173:_____/09:#0000031!RIV10-MZ0-00064173
|
http://linked.open...avai/riv/aktivita
| |
http://linked.open...avai/riv/aktivity
| |
http://linked.open...iv/cisloPeriodika
| |
http://linked.open...vai/riv/dodaniDat
| |
http://linked.open...aciTvurceVysledku
| |
http://linked.open.../riv/druhVysledku
| |
http://linked.open...iv/duvernostUdaju
| |
http://linked.open...titaPredkladatele
| |
http://linked.open...dnocenehoVysledku
| |
http://linked.open...ai/riv/idVysledku
| - RIV/00064173:_____/09:#0000031
|
http://linked.open...riv/jazykVysledku
| |
http://linked.open.../riv/klicovaSlova
| - BEACOPP, chemotherapy, Hodgkin´s lymphoma, PET, response assessment (en)
|
http://linked.open.../riv/klicoveSlovo
| |
http://linked.open...odStatuVydavatele
| - GB - Spojené království Velké Británie a Severního Irska
|
http://linked.open...ontrolniKodProRIV
| |
http://linked.open...i/riv/nazevZdroje
| |
http://linked.open...in/vavai/riv/obor
| |
http://linked.open...ichTvurcuVysledku
| |
http://linked.open...cetTvurcuVysledku
| |
http://linked.open...vavai/riv/projekt
| |
http://linked.open...UplatneniVysledku
| |
http://linked.open...v/svazekPeriodika
| |
http://linked.open...iv/tvurceVysledku
| - Kozák, Tomáš
- Marková, Jana
- Skopalová, M.
- Engert, A.
- Dietlein, M.
- Kobe, C.
- Dědečková, K.
- Eich, HT.
- Klasková, K.
- Plutschow, A.
|
http://linked.open...ain/vavai/riv/wos
| |
issn
| |
number of pages
| |